Cardiac fibrosis, a scarring process that impairs cardiac function and increases the risk of sudden death, remains difficult to detect at early stages with current imaging tools. ... Read more

Early detection with low-dose CT (LD-CT) reduces lung cancer mortality by 20%, yet eligibility is limited and patient compliance remains low. MyRepair is a mechanism-based blood test designed to identify high-risk individuals for LD-CT screening — independent of smoking history. ... Read more

Accurate detection of minimal residual disease (MRD) is critical for predicting relapse in hematological cancers. However, current diagnostic tools often fail when therapeutic antibodies mask target markers, leading to false negatives. ... Read more